
Doctoral Candidate Working Group on Infection and Immunology
Why did you choose to work in this particular field?
I chose to focus on the immunological aspects (i.e. macrophages) of lung cancer because of both personal experience and scientific curiosity. I lost my grandfather to cancer at a relatively young age, and unfortunately, millions of people experience the devastating effects of this disease every day. And while research has made tremendous progress over the past decade, the heterogeneity of cancer remains a major challenge, highlighting the need for continued efforts to move towards a cancer-free world.
In addition, I find the dual role of the immune system in cancer extremely fascinating. While our own immune system is originally designed to help us prevent and fight various diseases and infections, it paradoxically can also contribute to the progression of cancer. Understanding how to shift the immune system from a pro-tumoral to an anti-tumoral state is, in my opinion, one of the most promising avenues for developing more effective treatments. If we could successfully reprogram the immune system to consistently fight cancer rather than support its growth, we could take a significant step toward more effective and lasting cancer therapies.
How did you come to Fraunhofer ITEM?
I am originally from Belgium, where I also completed my university studies. After completing my master’s degree, I was looking for a Ph.D. position to further expand my expertise and knowledge. That’s when I came across Fraunhofer ITEM — thanks to one of my professors in Belgium, who put me into contact with Katherina. During the interview process, I learned that I would be part of the European Magicbullet::Reloaded consortium, which immediately caught my attention. Given my strong interest in cancer research, the opportunity to contribute to this field within an international research environment felt like the perfect fit for me.
Which project or achievement at Fraunhofer ITEM do you remember most fondly?
One of the experiences I look back on most fondly at Fraunhofer ITEM is being part of a European consortium. The many international meetings we had were not only highly educational but also incredibly inspiring. As a group of 15 next-generation researchers, we all shared the same goal of fighting cancer. But at the same time, we also came from vastly different educational backgrounds. This interdisciplinary environment fostered diverse perspectives and encouraged us to think outside the box. Collaborating with researchers from various fields broadened my scientific approach and reinforced the importance of teamwork in tackling complex challenges like cancer.
Furthermore, I truly enjoyed being a part of the precision-cut lung slices team at Fraunhofer ITEM. It was incredible to see how many patients were willing to donate a part of themselves to support the research we were conducting. Working with primary human lung tissue was both a privilege and a responsibility, and I was grateful for the opportunity to contribute to research that directly builds on patient generosity.
What was the most recent thing that amazed you?
The most recent thing that truly amazed me was the breathtaking beauty of Tenerife. Even though I’ve been here multiple times before, visiting the island always leaves me in awe and reminds me of how incredible nature can be. From its dramatic volcanic landscapes to its lush forests and stunning coastlines, the island feels like a place of endless wonder.
What always makes you laugh?
Spending time with friends and family, feeling the freedom when driving my motorcycle, traveling to and visiting new places, the sunshine on my face.